FDA clears Explant Express for ruptured breast implant removal. Explore what this means for surgical workflows, adoption risks, and explantation standardisation.
Diamond Lake Clinic introduces EXOMIND for depression care. Find out what this shift means for neuromodulation, evidence standards, and mental health treatment models.
Centivax has begun Phase 1 testing of its universal flu vaccine Centi-Flu 01. Find out what this trial could change for influenza prevention.
Explore why vein health supplements like VenEase are gaining traction, what they change in circulation care, and the risks regulators and clinicians are watching.
Hoth Therapeutics secures a U.S. patent for exon-skipping allergy therapy. Read what this means for immunology strategy, clinical risk, and future drug development.
StimLabs has secured FDA clearance for DermaForm, expanding its wound care portfolio. Find out what this changes for clinicians and the market.
New England Biolabs launches an automation-ready cfDNA extraction kit. Find out what this changes for liquid biopsy workflows and diagnostics development.
BioLife Solutions expands into cytokines through a Qkine agreement. Find out what this means for CGT manufacturing workflows and supplier strategy.
Randomized trial data show the FDA-cleared IpsiHand brain-computer interface improved chronic stroke recovery. Find out what this changes for rehab care.
AstraZeneca’s KALOS and LOGOS trials highlight triple inhaler therapy gains in asthma. Explore what this means for guidelines and payers.